| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Illumina, Inc. (ILMN) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. ILMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.50M | $567.10M | - | |
| Dir | 2.83M | $458.34M | -669,596 | |
| CEO | 82.1K | $13.29M | - | |
| VP | 41.9K | $6.79M | - | |
| VP | 33.0K | $5.35M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2021 | McGinnis Karen K | VP, Chief Accounting Officer | Sell | 666 | $486.75 | $324,175.50 | -30.2% | |
| Feb 16, 2021 | Flatley Jay T47 | Director | Sell | 4,500 | $504.13 | $2,268,582.55 | -2.4% | |
| Feb 5, 2021 | Tousi Susan H81 | SVP Product Development | Sell | 800 | $431.90 | $345,520.00 | -2.0% | |
| Feb 2, 2021 | Hoyt Aimee L74 | SVP, Chief People Officer | Sell | 57 | $444.84 | $25,355.88 | -2.4% | |
| Feb 2, 2021 | McGinnis Karen K | VP, Chief Accounting Officer | Sell | 72 | $444.84 | $32,028.48 | -4.5% | |
| Feb 2, 2021 | Flatley Jay T47 | Director | Sell | 4,000 | $444.84 | $1,779,360.00 | -2.2% | |
| Feb 1, 2021 | Desouza Francis A | President And CEO | Sell | 3,000 | $439.78 | $1,319,330.30 | -0.5% | |
| Jan 20, 2021 | Tousi Susan H81 | SVP Product Development | Sell | 2,500 | $400.00 | $1,000,000.00 | -5.8% | |
| Jan 19, 2021 | Flatley Jay T47 | Director | Sell | 4,000 | $382.48 | $1,529,920.00 | -2.2% | |
| Jan 11, 2021 | Hoyt Aimee L74 | SVP, Chief People Officer | Sell | 271 | $379.65 | $102,885.15 | -10.3% |